<DOC>
	<DOCNO>NCT02627859</DOCNO>
	<brief_summary>26 week open label study treatment Durolane OA pain ankle</brief_summary>
	<brief_title>26 Week Open Label Study Evaluating Single IA Injection DUROLANE SJ Treatment Osteoarthritis Pain Ankle</brief_title>
	<detailed_description>Single injection Durolane patient mild moderate OA ankle .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<criteria>1 . Females male age 19 85 year age 2 . Diagnosis mild moderate ( KL grade II III ) osteoarthritis ( OA ) study ankle joint , confirm radiograph take within previous six month OA contralateral ankle permissible provide OA symptom great study ankle . 3 . VAS ( 100mm ) AOS pain subscale score range 30mm 90mm study ankle 4 . Must willing discontinue use oral topical analgesia rescue use acetaminophen pain include OA pain study ankle . Must also willing discontinue acetaminophen rescue medication least 24 hour study visit 5 . Abstinence IA periarticular injection study ankle course trial , except Investigational Product 6 . Cooperative able communicate effectively Investigators 7 . Patients chronic ankle pain study ankle last 6 month without clinically significant improvement ankle pain past one month 8 . Body mass index ( BMI ) â‰¤ 35 kg/m2 . 9 . English literacy ability understand complete inform consent procedure 1 . Significant pain joint low back pain require chronic ongoing analgesic therapy 2 . Hindfoot deformities 3 . Substantial venous lymphatic stasis legs 4 . Presence one condition could confound pain functional assessment study ankle , e.g. , plantar fasciitis , Achilles tendonitis , sprain foot , degenerative joint disease foot . 5 . Clinicallyapparent tense effusion , sign misalignment instability study ankle 6 . Ankle xray finding acute fracture , severe loss bone density , avascular necrosis and/or severe deformity study ankle 7 . Surgery study ankle within previous 12 month 8 . Unable abstain treatment NSAIDs pain management medication week ( five halflives drug , whichever long ) prior Baseline Visit . 9 . Unable abstain treatment topical analgesic washout period prior screen visit throughout duration study . Washout period topical analgesic base clinical investigator judgment ( ~ day ) . 10 . Inability tolerate acetaminophen rescue medication use . 11 . IA local periarticular corticosteroid injection study ankle within previous three month ; joint within previous month ; oral corticosteroid within previous month . Steroid inhalant permit patient stable regimen past month remain regimen throughout course trial 12 . IA injection hyaluronic acid study ankle within last 9 month 13 . Previous allergic reaction HA lidocaine product allergy . 14 . Treatment glucosamine/chondroitin sulfate initiate within past three month , dosage stable past three month 15 . Change physical therapy study ankle within one month precede screening , expect change physical therapy ankle study 16 . Planned surgical procedure study period . 17 . Previous history presence septic arthritis study ankle 18 . Active skin disease infection area injection site 19 . Alcohol drug abuse determine Investigator use alcohol control pain ; Use illicit drug include cannabis . 20 . Systemic inflammatory condition autoimmune disease infection rheumatoid arthritis , inflammatory arthritis , ankylose spondylitis , psoriatic arthritis , reactive arthritis , gout/ acute pseudo gout connective tissue disease 21 . Uncontrolled hypothyroidism 22 . Treatment anticoagulant ( except acetylsalicylic acid maximum 325mg/day ) 23 . Any medical condition opinion investigator make patient unsuitable inclusion ( e.g. , severe progressive chronic disease , malignancy , bleed disorder , fibromyalgia ) 24 . Pregnant breastfeed woman woman childbearing potential practicing adequate contraception . 25 . Subjects opinion investigator unsuitable inclusion ( e.g. , subject likely avoid therapy , subject likely stay study plan relocate whole study period , subject likely unreliable ) 26 . Concurrent participation clinical study participation within precede 30 day</criteria>
	<gender>All</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>